Members of Farmavita.net are invited to publish their business for sale.

Profitable and Modern Russian CMO

Sale

Description

Profitable and Modern Russian CMO with long term contracts for sale Founded in 2011, State of the art, audited by TOP MNC pharma companies, CMO located in Moscow area with comfortable transport junction, Long-term contract manufacturing agreements (packaging) with 5+ TOP MNC pharmaceutical companies. Total area - 1.600 m2, including equipment stock, analytical laboratory and microbiological laboratory. CMO contracts includes primary and secondary packaging with the release control of the sterile solutions for injections in ampoules and syringes; 
Manufacturing capacities – 9 mln. pack. per year and used now 20%. Possibility to expand production capacities to oral solid (tablets and capsules with the capacity of 2.5 bln. tab/caps. per year and/or non-sterile oral liquids. 
The manufacturing site is approved by Russian GMP license and equipped with necessary communications and engineering 
equipment of the leading worldwide manufacturers including System for preparation, storage and distribution of purified water; Power supply system;
Air preparation and conditioning system;
Compressed air preparation and distribution system; Climatic parameter monitoring system; Security alarm and video monitoring system; Cooling-compressor equipment;
Blister and cartooning machines. New equipment value app 1 M, land and building in on long term rent contract. 54 employees, annual revenue 1.4 M Euro, profitable, no loans from the banks. Asking price 9 M Euro. More information conphar@mail.ru Please indicate subject "Profitable and Modern Russian CMO with long term contracts for sale "

Ad details

Ad ID : 946

Advertiser details

+79163554542
Contact Advertiser

Add comment

 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
783 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
645 Views
Profitable and Modern Russian CMO with long...
610 Views
Adalimumab API available: - from EU cGMP...
10356 Views
Infliximab API available: - from EU cGMP...
626 Views
Normal 0 false false false EN-US X-NONE HE /*...
603 Views
Start-up pharmaceutical company from South...
2054 Views